Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Department of Neurosurgery, Yokomhama City University Medical Center, Yokohama, Kanagawa, Japan.
Interv Neuroradiol. 2023 Aug;29(4):426-433. doi: 10.1177/15910199221095786. Epub 2022 Apr 21.
Parent artery occlusion (PAO) is an effective treatment for hemorrhagic diseases associated with the internal carotid artery. There are several reports of long-term cerebral infarction or the formation of de novo cerebral aneurysms following PAO.
We retrospectively reviewed these complications in 38 patients who underwent PAO for therapeutic treatment. We investigated perioperative cerebral infarctions, long-term cerebral infarctions, and de novo aneurysms.
The mean age of the patients was 64.0 years, and 25 patients (65.8%) were female. The causative diseases were unruptured (n = 19; 50.0%) and ruptured (n = 8; 21.1%) aneurysms. PAO was performed after ischemic tolerance was assessed with balloon test occlusion (BTO), and BTO was performed in 34 patients, of whom 25 (73.5%) had ischemic tolerance. Twenty-six patients (68.4%) were treated with PAO alone, eight (23.5%) with low-flow bypass, and six (17.6%) with high-flow bypass. Perioperative complications occurred in five patients (13.2%): two of the 26 patients (7.7%) who underwent scheduled treatment and three of the 12 patients (25.0%) who underwent emergency treatment. One patient (2.6%) had long-term de novo aneurysm, and none developed cerebral infarction.
These results showed that the assessment of ischemic tolerance by performing BTO and appropriate revascularization in scheduled treatments are important to reduce perioperative and long-term cerebral infarctions. PAO must be performed with greater caution in emergency treatment.
颈内动脉相关出血性疾病的有效治疗方法是闭塞载瘤动脉(PAO)。有几项关于 PAO 后长期脑梗死或新发脑动脉瘤形成的报道。
我们回顾性分析了 38 例行 PAO 治疗的患者的这些并发症。我们调查了围手术期脑梗死、长期脑梗死和新发动脉瘤。
患者平均年龄为 64.0 岁,25 例(65.8%)为女性。病因包括未破裂(n=19;50.0%)和破裂(n=8;21.1%)动脉瘤。在进行球囊试验闭塞(BTO)评估缺血耐受后进行 PAO,34 例患者进行了 BTO,其中 25 例(73.5%)有缺血耐受。26 例(68.4%)患者单独行 PAO,8 例(23.5%)行低流量搭桥,6 例(17.6%)行高流量搭桥。围手术期并发症发生在 5 例患者(13.2%):26 例计划治疗患者中有 2 例(7.7%),12 例紧急治疗患者中有 3 例(25.0%)。1 例(2.6%)患者出现长期新发动脉瘤,无一例发生脑梗死。
这些结果表明,通过 BTO 评估缺血耐受和在计划治疗中进行适当的血运重建,对于减少围手术期和长期脑梗死是重要的。在紧急治疗中必须更加谨慎地进行 PAO。